Interstitial magnetic resonance lymphography using a polymeric T1 contrast agent: Initial experience with gadomer-17

Investigative Radiology

Volumn 37, Issue 3, 2002, Pages 146-151

  Misselwitz, Bernd ^a   Schmitt Willich, Heribert ^a   Michaelis, Marten ^a   Oellinger, Johann J ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

Contrast agents; Interstitial MR lymphography; Lymph nodes; MR imaging

Indexed keywords

CONTRAST MEDIUM; DENDRIMER; GADOMER 17;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STAGING; CONTRAST ENHANCEMENT; DOG; DOSE RESPONSE; EQUIPMENT; FEMALE; IMAGE QUALITY; INGUINAL LYMPH NODE; INTERSTITIUM; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM; LYMPHOGRAPHY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING;

EID: 0036119375     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200203000-00007     Document Type: Article

References (24)

1. Cancer statistics, 1999
2. Accuracy of CT in detecting intraabdominal and pelvic lymph node metastases from pelvic cancers
3. Macromolecular intravenous contrast agent for MR lymphography: Characterization and efficacy studies
4. Imaging of nodal metastases in the head and neck
5. Nodal size of metastatic squamous cell carcinoma of the neck
6. Magnetic resonance imaging of the lymph nodes: Comparison with CT
7. Lymphatic imaging
8. Indirekte lymphographie: Indikationen, technik, klinische ergebnisse
9. Contrast-enhanced lymphography. CT or MR imaging?
10. Investigation of mechanisms influencing the accumulation of ultrasmall superparamagnetic iron oxide particles in lymph nodes
11. Magnetic resonance lymphography. Enhancement patterns using superparamagnetic nanoparticles
12. Lymph node metastases: Safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles - Initial clinical experience
13. Interstitial MR lymphography with iron oxide particles: Results in tumor-free and VX2 tumor-bearing rabbits
14. Interstitial MR lymphography using Gd-carrying liposomes
15. Experimental lymph node metastases: Enhanced detection with MR lymphography
16. Characterization of reactive versus tumor-bearing lymph nodes with interstitial magnetic resonance lymphography in an animal model
17. MR lymphography with a lymphotropic T1-type MR contrast agent: Gd-DTPA-PGM
18. Interstitial MR and CT lymphography with Gd-DTPA-co-α,ω-diaminoPEG(1450) and Gd-DTPA-co-1,6-diaminohexane polymers: Preliminary experience
19. MR lymphography after interstitial injection of contrast media
20. Gadofluorine 8: Initial experience with a new contrast medium for interstitial MR lymphography
21. Time course of nodal enhancement with CT X-ray nanoparticle contrast agents: Effect of particle size and chemical structure
22. Indirect computed tomography lymphography using iodinated nanoparticles: Time and dose response in normal canine lymph nodes
23. A new dedicated contrast agent for MR angiography
24. Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent